Report Detail
Global Cell Therapy and Tissue Engineering Market Growth (Status and Outlook) 2019-2024
- RnM3574916 |
- 05 July, 2019 |
- Global |
- 156 Pages |
- LPI(LP Information) |
- Other
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules.
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules. Cell therapy, genetically modified cell therapy, gene therapy and tissue engineering are the four pillars of Regenerative Medicine (RM). These therapies have the potential to beneficially alter the quality of life and improve the health of patients with cell defects, genetic diseases, neurodegenerative diseases, tissue malignancies and other medical conditions.
According to this study, over the next five years the Cell Therapy and Tissue Engineering market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Cell Therapy and Tissue Engineering business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Cell Therapy and Tissue Engineering market by product type, application, key companies and key regions.
This study considers the Cell Therapy and Tissue Engineering value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Cell Therapy
Tissue Engineering
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Cell Defects
Genetic Diseases
Neurodegenerative Diseases
Tissue Malignancies
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Betalin Therapeutics
BioCardia, Inc
BioReliance Corporation
Biosolution Co., Ltd.
Brainstorm Cell Therapeutics, Inc
MaxCyte, Inc
Medigene AG
MEDIPOST CO., Ltd.
Mesoblast Limited
Miromatrix Medical, Inc.
MolMed S.p.A
Mustang Bio, Inc
NantKwest, Inc.
Neuralstem, Inc
NexImmune, Inc.
Nohla Therapeutics, Inc
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Rubius Therapeutics, Inc.
Sangamo Therapeutics, Inc
Voyager Therapeutics, Inc
Waisman Biomanufacturing
WindMIL Therapeutics, Inc.
Wuxi App Tec, Inc.
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cell Therapy and Tissue Engineering market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cell Therapy and Tissue Engineering market by identifying its various subsegments.
Focuses on the key global Cell Therapy and Tissue Engineering players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cell Therapy and Tissue Engineering with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Cell Therapy and Tissue Engineering submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Cell Therapy and Tissue Engineering Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Cell Therapy and Tissue Engineering Market Size 2014-2024
- 2.1.2 Cell Therapy and Tissue Engineering Market Size CAGR by Region
- 2.2 Cell Therapy and Tissue Engineering Segment by Type
- 2.2.1 Cell Therapy
- 2.2.2 Cell Therapy
- 2.3 Cell Therapy and Tissue Engineering Market Size by Type
- 2.3.1 Global Cell Therapy and Tissue Engineering Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type (2014-2019)
- 2.4 Cell Therapy and Tissue Engineering Segment by Application
- 2.4.1 Cell Defects
- 2.4.2 Genetic Diseases
- 2.4.3 Neurodegenerative Diseases
- 2.4.4 Tissue Malignancies
- 2.4.5 Others
- 2.5 Cell Therapy and Tissue Engineering Market Size by Application
- 2.5.1 Global Cell Therapy and Tissue Engineering Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Application (2014-2019)
3 Global Cell Therapy and Tissue Engineering by Players
- 3.1 Global Cell Therapy and Tissue Engineering Market Size Market Share by Players
- 3.1.1 Global Cell Therapy and Tissue Engineering Market Size by Players (2017-2019)
- 3.1.2 Global Cell Therapy and Tissue Engineering Market Size Market Share by Players (2017-2019)
- 3.2 Global Cell Therapy and Tissue Engineering Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Cell Therapy and Tissue Engineering by Regions
- 4.1 Cell Therapy and Tissue Engineering Market Size by Regions
- 4.2 Americas Cell Therapy and Tissue Engineering Market Size Growth
- 4.3 APAC Cell Therapy and Tissue Engineering Market Size Growth
- 4.4 Europe Cell Therapy and Tissue Engineering Market Size Growth
- 4.5 Middle East & Africa Cell Therapy and Tissue Engineering Market Size Growth
5 Americas
- 5.1 Americas Cell Therapy and Tissue Engineering Market Size by Countries
- 5.2 Americas Cell Therapy and Tissue Engineering Market Size by Type
- 5.3 Americas Cell Therapy and Tissue Engineering Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Cell Therapy and Tissue Engineering Market Size by Countries
- 6.2 APAC Cell Therapy and Tissue Engineering Market Size by Type
- 6.3 APAC Cell Therapy and Tissue Engineering Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Cell Therapy and Tissue Engineering by Countries
- 7.2 Europe Cell Therapy and Tissue Engineering Market Size by Type
- 7.3 Europe Cell Therapy and Tissue Engineering Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Cell Therapy and Tissue Engineering by Countries
- 8.2 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Type
- 8.3 Middle East & Africa Cell Therapy and Tissue Engineering Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Cell Therapy and Tissue Engineering Market Forecast
- 10.1 Global Cell Therapy and Tissue Engineering Market Size Forecast (2019-2024)
- 10.2 Global Cell Therapy and Tissue Engineering Forecast by Regions
- 10.2.1 Global Cell Therapy and Tissue Engineering Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Cell Therapy and Tissue Engineering Forecast by Type
- 10.8 Global Cell Therapy and Tissue Engineering Forecast by Application
11 Key Players Analysis
- 11.1 Betalin Therapeutics
- 11.1.1 Company Details
- 11.1.2 Cell Therapy and Tissue Engineering Product Offered
- 11.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Betalin Therapeutics News
- 11.2 BioCardia, Inc
- 11.2.1 Company Details
- 11.2.2 Cell Therapy and Tissue Engineering Product Offered
- 11.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 BioCardia, Inc News
- 11.3 BioReliance Corporation
- 11.3.1 Company Details
- 11.3.2 Cell Therapy and Tissue Engineering Product Offered
- 11.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 BioReliance Corporation News
- 11.4 Biosolution Co., Ltd.
- 11.4.1 Company Details
- 11.4.2 Cell Therapy and Tissue Engineering Product Offered
- 11.4.3 Biosolution Co., Ltd. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Biosolution Co., Ltd. News
- 11.5 Brainstorm Cell Therapeutics, Inc
- 11.5.1 Company Details
- 11.5.2 Cell Therapy and Tissue Engineering Product Offered
- 11.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Brainstorm Cell Therapeutics, Inc News
- 11.6 MaxCyte, Inc
- 11.6.1 Company Details
- 11.6.2 Cell Therapy and Tissue Engineering Product Offered
- 11.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 MaxCyte, Inc News
- 11.7 Medigene AG
- 11.7.1 Company Details
- 11.7.2 Cell Therapy and Tissue Engineering Product Offered
- 11.7.3 Medigene AG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Medigene AG News
- 11.8 MEDIPOST CO., Ltd.
- 11.8.1 Company Details
- 11.8.2 Cell Therapy and Tissue Engineering Product Offered
- 11.8.3 MEDIPOST CO., Ltd. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 MEDIPOST CO., Ltd. News
- 11.9 Mesoblast Limited
- 11.9.1 Company Details
- 11.9.2 Cell Therapy and Tissue Engineering Product Offered
- 11.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Mesoblast Limited News
- 11.10 Miromatrix Medical, Inc.
- 11.10.1 Company Details
- 11.10.2 Cell Therapy and Tissue Engineering Product Offered
- 11.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Miromatrix Medical, Inc. News
- 11.11 MolMed S.p.A
- 11.12 Mustang Bio, Inc
- 11.13 NantKwest, Inc.
- 11.14 Neuralstem, Inc
- 11.15 NexImmune, Inc.
- 11.16 Nohla Therapeutics, Inc
- 11.17 ReNeuron Group plc
- 11.18 Richter-Helm BioLogics GmbH & Co. KG
- 11.19 RoosterBio, Inc
- 11.20 RoslinCT
- 11.21 Rubius Therapeutics, Inc.
- 11.22 Sangamo Therapeutics, Inc
- 11.23 Voyager Therapeutics, Inc
- 11.24 Waisman Biomanufacturing
- 11.25 WindMIL Therapeutics, Inc.
- 11.26 Wuxi App Tec, Inc.
- 11.27 ReNeuron Group plc
- 11.28 Richter-Helm BioLogics GmbH & Co. KG
- 11.29 RoosterBio, Inc
- 11.30 RoslinCT
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Cell Therapy and Tissue Engineering. Industry analysis & Market Report on Cell Therapy and Tissue Engineering is a syndicated market report, published as Global Cell Therapy and Tissue Engineering Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Cell Therapy and Tissue Engineering market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
